Abstract
Several oncogenic pathways may lead to cancer. Pharmaceutical research develops efficacious compounds to inhibit these pathways. Current inhibitor drugs may block several pathways simultaneously but cause adverse and side effects. Therefore, we designed novel acyl thiourea derivatives containing pyrazole ring to selectively inhibit a kinase dependent pathway in cancer. In this study, breast and bone cancer cells were employed to monitor this selectivity. Since metastatic breast cancer spreads to bone, MCF-7 along with epithelial (Saos-2) and fibroblast (MG-63) human bone cancer cell lines were used to observe inhibitory effects of the synthesized compounds. It has been reported that Estrogen receptor α (ER-α) and Aurora kinase A and B are involved in different pathways at breast and bone cancer mechanism. Synthesized novel inhibitors presented in this work effectively and selectively bind to Aurora kinase A and B but do not interact with ER-α however; a generic inhibitor PHA-739358 binds to all three enzymes. This improved binding mode of the novel inhibitors may be a useful therapeutic strategy for the treatment of breast and bone cancer approaches and provides potency to personalized medicine.
Keywords: Aurora kinases, bone cancer, breast cancer, estrogen receptor alpha, pyrazoles.
Letters in Drug Design & Discovery
Title:Acyl Thiourea Derivatives Containing Pyrazole Ring Selective Targeting of Human Aurora Kinases in Breast and Bone Cancer
Volume: 12 Issue: 3
Author(s): Aykut Ozgur, Eren Yenidunya, Irfan Koca and Yusuf Tutar
Affiliation:
Keywords: Aurora kinases, bone cancer, breast cancer, estrogen receptor alpha, pyrazoles.
Abstract: Several oncogenic pathways may lead to cancer. Pharmaceutical research develops efficacious compounds to inhibit these pathways. Current inhibitor drugs may block several pathways simultaneously but cause adverse and side effects. Therefore, we designed novel acyl thiourea derivatives containing pyrazole ring to selectively inhibit a kinase dependent pathway in cancer. In this study, breast and bone cancer cells were employed to monitor this selectivity. Since metastatic breast cancer spreads to bone, MCF-7 along with epithelial (Saos-2) and fibroblast (MG-63) human bone cancer cell lines were used to observe inhibitory effects of the synthesized compounds. It has been reported that Estrogen receptor α (ER-α) and Aurora kinase A and B are involved in different pathways at breast and bone cancer mechanism. Synthesized novel inhibitors presented in this work effectively and selectively bind to Aurora kinase A and B but do not interact with ER-α however; a generic inhibitor PHA-739358 binds to all three enzymes. This improved binding mode of the novel inhibitors may be a useful therapeutic strategy for the treatment of breast and bone cancer approaches and provides potency to personalized medicine.
Export Options
About this article
Cite this article as:
Ozgur Aykut, Yenidunya Eren, Koca Irfan and Tutar Yusuf, Acyl Thiourea Derivatives Containing Pyrazole Ring Selective Targeting of Human Aurora Kinases in Breast and Bone Cancer, Letters in Drug Design & Discovery 2015; 12 (3) . https://dx.doi.org/10.2174/1570180811666141001005129
DOI https://dx.doi.org/10.2174/1570180811666141001005129 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Transcription Factor ETS-1: Its Role in Tumour Development and Strategies for its Inhibition
Mini-Reviews in Medicinal Chemistry ANN and Bayesian Classification Models for Virtual Screening of Endocrine-Disrupting Chemicals
Combinatorial Chemistry & High Throughput Screening Epidermal Stem Cells - Role in Normal, Wounded and Pathological Psoriatic and Cancer Skin
Current Stem Cell Research & Therapy Towards Selective Kir6.2/SUR1 Potassium Channel Openers, Medicinal Chemistry and Therapeutic Perspectives
Current Medicinal Chemistry The Urokinase Receptor as a Potential Target in Cancer Therapy
Current Pharmaceutical Design Trabectedin as a New Chemotherapy Option in the Treatment of Relapsed Platinum Sensitive Ovarian Cancer
Current Pharmaceutical Design Peptide-Receptor Ligands and Multivalent Approach
Anti-Cancer Agents in Medicinal Chemistry Multiple Perspectives in Anti-cancer Drug Discovery: From old Targets and Natural Products to Innovative Computational Approaches
Anti-Cancer Agents in Medicinal Chemistry Connexins as Precocious Markers and Molecular Targets for Chemical and Pharmacological Agents in Carcinogenesis
Current Medicinal Chemistry Antimicrobial Activity of Royal Jelly
Anti-Infective Agents Rational Design and Development of RDP58
Current Pharmaceutical Design Probiotic Beverage with Soy Isoflavone Consumption for Breast Cancer Prevention: A Case-control Study
Current Nutrition & Food Science Regulation of Intracellular Cardiomyocyte Calcium Stores by Peptides: A New Approach to Cardiac Protection
Current Medicinal Chemistry Antisense Oligonucleotides as an Innovative Therapeutic Strategy in the Treatment of High-Grade Gliomas
Recent Patents on CNS Drug Discovery (Discontinued) Computational & Statistical Methodologies to Identify Biomarkers in Cancer
Current Cancer Therapy Reviews A Review of Biomarkers in Mood and Psychotic Disorders: A Dissection of Clinical vs. Preclinical Correlates
Current Neuropharmacology Behavioral Decision Research Intervention Reduces Risky Sexual Behavior
Current HIV Research ProBDNF is a Novel Mediator of the Interaction Between MDA-MB- 231 Breast Cancer Cells and Brain Microvascular Endothelial Cells
Current Molecular Medicine Molecular Modeling Based Synthesis and Evaluation of <i>In vitro</i> Anticancer Activity of Indolyl Chalcones
Current Topics in Medicinal Chemistry On The Edge of Validation – Cancer Protease Fibroblast Activation Protein
Mini-Reviews in Medicinal Chemistry